Stock Scorecard



Stock Summary for Waters Corp (WAT) - $384.14 as of 12/23/2025 2:18:03 PM EST

Total Score

7 out of 30

Safety Score

55 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for WAT

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for WAT

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for WAT

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for WAT

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for WAT (55 out of 100)

Stock Price Rating (Max of 10) 10
Historical Stock Price Rating (Max of 10) 10
Stock Price Trend (Max of 10) 7
Book Value (Max of 10) 8
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 5
Trading Volume (Max of 10) 5
Price to Earnings (Max of 10) 5
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for WAT

Waters Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 12/23/2025 4:08:00 PM
Your 15 Assertio shares become 1 next week—here’s what happens 12/22/2025 9:08:00 PM
Did Revvity’s New AI Discovery Platform (RVTY) Quietly Redefine Its Innovation Moat? 12/22/2025 11:23:00 AM
Voya Investment Management LLC Lowers Stake in Waters Corporation $WAT 12/21/2025 12:19:00 PM
Assenagon Asset Management S.A. Boosts Holdings in Waters Corporation $WAT 12/20/2025 9:08:00 AM
Will Bruker’s (BRKR) AbCellera Settlement and Beacon Royalties Deal Change Its Investment Narrative? 12/19/2025 7:08:00 AM
Form DEF 14A BECTON DICKINSON & CO For: Dec 12 12/18/2025 4:07:00 PM
Is Invesco S&P 500 Equal Weight Health Care ETF (RSPH) a Strong ETF Right Now? 12/18/2025 3:09:00 PM
Halper Sadeh LLC Encourages WAT, CSGS, SWKS Shareholders to Contact the Firm to Discuss Their Rights 12/16/2025 7:21:00 PM
Waters (WAT) Sees Price Target Raised by Wells Fargo | WAT Stock News 12/15/2025 7:28:00 PM

Financial Details for WAT

Company Overview

Ticker WAT
Company Name Waters Corp
Country USA
Description Waters Corporation (WAT) is a premier global leader in analytical instrumentation, software, and services that cater to laboratories in the pharmaceutical, environmental, food and beverage, and academic sectors. Based in Milford, Massachusetts, the company is renowned for its innovations in liquid chromatography, mass spectrometry, and thermal analysis, which significantly optimize scientific research and operational efficiency. Waters' strong emphasis on technological advancement and strategic partnerships positions it effectively to support institutions in developing groundbreaking products, while also enabling it to capitalize on emerging growth opportunities in the global market.
Sector Name HEALTHCARE
Industry Name DIAGNOSTICS & RESEARCH
Most Recent Quarter 9/30/2025
Next Earnings Date 2/11/2026

Stock Price History

Last Day Price 384.14
Price 4 Years Ago 372.60
Last Day Price Updated 12/23/2025 2:18:03 PM EST
Last Day Volume 471,143
Average Daily Volume 599,442
52-Week High 423.56
52-Week Low 275.05
Last Price to 52 Week Low 39.66%

Valuation Measures

Trailing PE 34.73
Industry PE 38.97
Sector PE 135.38
5-Year Average PE 31.98
Free Cash Flow Ratio 49.82
Industry Free Cash Flow Ratio 63.49
Sector Free Cash Flow Ratio 32.38
Current Ratio Most Recent Quarter 1.53
Total Cash Per Share 7.71
Book Value Per Share Most Recent Quarter 39.16
Price to Book Ratio 9.66
Industry Price to Book Ratio 343.01
Sector Price to Book Ratio 56.98
Price to Sales Ratio Twelve Trailing Months 7.37
Industry Price to Sales Ratio Twelve Trailing Months 4.57
Sector Price to Sales Ratio Twelve Trailing Months 16.53
Analyst Buy Ratings 5
Analyst Strong Buy Ratings 0

Share Statistics

Total Shares Outstanding 59,548,000
Market Capitalization 22,874,768,720
Institutional Ownership 100.33%

Dividends

Ex-Dividend Date 11/26/1996
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0100
Total Years Dividend Increasing 1
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY -7.70%
Annual Earnings Growth -0.69%
Reported EPS 12 Trailing Months 11.06
Reported EPS Past Year 7.70
Reported EPS Prior Year 11.87
Net Income Twelve Trailing Months 648,813,000
Net Income Past Year 637,834,000
Net Income Prior Year 642,234,000
Quarterly Revenue Growth YOY 8.00%
5-Year Revenue Growth 4.22%
Operating Margin Twelve Trailing Months 27.40%

Balance Sheet

Total Cash Most Recent Quarter 459,118,000
Total Cash Past Year 324,421,000
Total Cash Prior Year 395,076,000
Net Cash Position Most Recent Quarter -488,088,000
Net Cash Position Past Year -1,302,067,000
Long Term Debt Past Year 1,626,488,000
Long Term Debt Prior Year 2,305,513,000
Total Debt Most Recent Quarter 947,206,000
Equity to Debt Ratio Past Year 0.53
Equity to Debt Ratio Most Recent Quarter 0.71
Total Stockholder Equity Past Year 1,828,507,000
Total Stockholder Equity Prior Year 1,150,341,000
Total Stockholder Equity Most Recent Quarter 2,330,693,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 602,265,000
Free Cash Flow Per Share Twelve Trailing Months 10.11
Free Cash Flow Past Year 619,642,000
Free Cash Flow Prior Year 442,177,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 3.60
MACD Signal 7.67
20-Day Bollinger Lower Band 258.64
20-Day Bollinger Middle Band 338.95
20-Day Bollinger Upper Band 419.26
Beta 1.16
RSI 44.71
50-Day SMA 348.07
150-Day SMA 323.53
200-Day SMA 322.54

System

Modified 12/23/2025 10:49:20 AM EST